Evidence map›Paper›PMID 41767011›Full record

ArticleFrontiers in neurology

The role of pallidotomy in the precision medicine era.

Giacomo Garone, Alice Innocenti, Alessandro De Benedictis, Maria Camilla Rossi-Espagnet, Franco Randi, Donatella Lettori, Simone Reali, Flaminia Frascarelli, Alessandra Savioli, Silvia Cossu and 4 more

Abstract read
In one paragraph

Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Giacomo GaroneNeurology, Epilepsy and Movement Disorders Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Alice InnocentiNeurology, Epilepsy and Movement Disorders Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Alessandro De BenedictisNeurosurgery Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Maria Camilla Rossi-EspagnetDiagnostic and Interventional Neuroradiology Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Franco RandiNeurosurgery Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Donatella LettoriUnit of Neurorehabilitation, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Simone RealiAnesthesia and Critical Care Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Flaminia FrascarelliUnit of Neurorehabilitation, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Alessandra SavioliAnesthesia and Critical Care Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Silvia CossuNeurology Unit, Pediatric Hospital Antonio Cao, Brotzu Hospital Trust, Cagliari, Italy.
Laura CantonettiUnit of Neurorehabilitation, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Nazaret InfanteDepartment of Neurosurgery, Hospital del Mar, Barcelona, Spain.
Nicola SpecchioNeurology, Epilepsy and Movement Disorders Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Carlo Efisio MarrasDepartment of Neurosurgery, Hospital del Mar, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The use of radiofrequency pallidotomy (RP) for medically refractory dystonia has markedly declined since the introduction of deep brain stimulation (DBS). Conditions such as severe cognitive impairment, poor nutritional status, or acquired dystonia-common in children with severe dystonia-may limit DBS eligibility or benefit. In these cases, RP may represent a valuable alternative. Evidence on RP in this population remains scarce, mostly based on small case-series with limited follow-up. We retrospectively analyzed RP safety, feasibility and long-term outcomes in children with medically refractory dystonia. Methods: Records of patients who underwent RP at Bambino Gesù Children's Hospital were reviewed. Outcomes were retrospectively assessed through the Clinical Global Impression-Improvement scale. For patients with a history of status dystonicus (SD), recurrence was used as outcome measure. Results: Eighteen patients underwent 21 procedures. Sixteen received bilateral simultaneous pallidotomy; two unilateral pallidotomy after GPi-DBS removal due to infection. Three patients required repeated surgery for recurrent-SD. Ten had acquired dystonia (cerebral palsy, CP), five genetically confirmed dystonia, three idiopathic dystonia. Three were followed for three months or less; in the others, mean follow-up was 6.62 ± 3.65 years. Three months postoperatively, 12 of 16 patients improved (1 "very much improved," 2 "much improved," 9 "minimally improved"), 2 were unchanged and 2 minimally worsened. At last follow-up (15 patients), 1 remained "very much improved," 2 "minimally improved," 3 "unchanged," 6"minimally worsened," 3 "much worsened." Among six patients treated for ongoing-SD, crises abated over 50.7 ± 27.8 days. SD recurred in 8 patients (5 CP, 1 genetic, 2 idiopathic) after a mean of 20.3 ± 19.8 months. Conclusion: RP emerges as a feasible rescue-therapy for severe medically refractory SD. Most patients show meaningful short-term improvement, but beneficial effects tend to decline over time, with high rate of SD recurrence-particularly in dyskinetic-CP. This may reflect suboptimal lesions' location and/or size, progressive disease course or re-emergence of dystonia through different networks. In this light, RP should be considered when DBS is contraindicated, the risk of hardware-related complications outweighs the advantages of an adjustable system, or in patients with limited life expectancy, where an irreversible yet effective rescue intervention is clinically justified.

Indexed as

ablative surgerychildrendystoniapallidotomyradiofrequency

Identifiers

PMID41767011
PMCPMC12945792

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.